Leptin and cardiac cachexia: marker or mediator?
Cleland, J.G.; Clark, A.L.
European Heart Journal 19(10): 1421-1422
1998
ISSN/ISBN: 0195-668X PMID: 9820983 Document Number: 495792
Document emailed within 1 workday
Related Documents
Hladík, M.; Olosová, A.; Neiser, J.; Zaoral, T. 2005: Procalcitonin--a marker and mediator of inflammation Acta Chirurgiae Plasticae 47(2): 51-54Stewart, D.J. 1990: Endothelin-1--marker or mediator of vascular disease? Canadian Journal of Cardiology 6(8): Viii
Aguilera, A.; Bajo, M.A.; Rebollo, F.; Díez, J.J.; Díaz, C.; Paiva, A.; Codoceo, R.; Selgas, R. 2002: Leptin as a marker of nutrition and cardiovascular risk in peritoneal dialysis patients Advances in Peritoneal Dialysis. Conference on Peritoneal Dialysis 18: 212-217
Mayer, G.; Schomerus, H. 1977: Synthesis rates of albumin and fibrinogen in patients with cardiac and pulmonary cachexia Acta Hepato-Gastroenterologica 24(2): 82-85
Kozlov, I.A.; Meshcheriakov, A.V.; Semenov, V.A.; Kudriashova, M.I.; Lanskaia, I.M. 1984: Examination and preoperative preparation of cardiosurgery patients with cardiac cachexia syndrome Anesteziologiia i Reanimatologiia 4: 3-8
Hsu, L.F.; Koh, T.H.; Lim, Y.L. 2000: Cardiac marker point-of-care testing: evaluation of rapid on-site biochemical marker analysis for diagnosis of acute myocardial infarction Annals of the Academy of Medicine Singapore 29(4): 421-427
Meshcheriakov, A.V.; Shabalkin, B.V.; Kozlov, I.A.; Bobkov, V.V.; Kuznetsova, L.M. 1983: The informative value of anthropometry and echocardiography in evaluation of the degree of preoperative cardiac cachexia in cardiosurgical patients Anesteziologiia i Reanimatologiia 3: 8-11
Han, Y.-s.; Zhuang, Q.-l.; Wu, G.-h. 2012: Proteolysis induce factor in the digestive systematic cancer cachexia patients: its expression and role in cancer cachexia Zhonghua Wei Chang Wai Ke Za Zhi 15(12): 1287-1290
Ebihara, K. 2011: Role of leptin--AMPK pathway on the regulation of appetite and implication of leptin resistance Nihon Rinsho. Japanese Journal of Clinical Medicine 69(Suppl 1): 121-126
Markowska, A.; Rucinski, M.; Drews, K.; Malendowicz, L.K. 2005: Further studies on leptin and leptin receptor expression in myometrium and uterine myomas European Journal of Gynaecological Oncology 26(5): 517-525
Jiskra, J.; Haluzík, M.; Svobodová, J.; Haluzíková, D.; Nedvídková, J.; Parízková, J.; Kotrlíková, E. 2000: Serum leptin levels and soluble leptin receptors in female patients with anorexia nervosa Casopis Lekaru Ceskych 139(21): 660-663
Okmen, E.; Kasikcioglu, H.; Sanli, A.; Uyarel, H.; Cam, N. 2005: Correlations between cardiac troponin I, cardiac troponin T, and creatine phosphokinase MB elevation following successful percutaneous coronary intervention and prognostic value of each marker Journal of Invasive Cardiology 17(2): 63-67
Popruk, S.; Tungtrongchitr, R.; Pongpaew, P.; Phonrat, B.; Tungtrongchitr, A.; Tribunyatkul, S.; Paksanont, S.; Vudhivai, N.; Schelp, F.P. 2005: Relationship between soluble leptin receptor, leptin, lipid profiles and anthropometric parameters in overweight and obese Thai subjects Journal of the Medical Association of Thailand 88(2): 220-227
Daves, M.; Salvagno, G.L.; Cemin, R.; Gelati, M.; Cervellin, G.; Guidi, G.C.; Lippi, G. 2012: Influence of Hemolysis on Routine Laboratory Cardiac Marker Testing Clinical Laboratory 58(3-4): 333-336
Grigoriadi, N.E.; Vasiletz, L.M.; Ratanova, E.A.; Karpunina, n.S.; Tuev, A.V. 2013: Changes in the serum marker of cardiac fibrosis and inflammation associated with atrial fibrillation Klinicheskaia Meditsina 91(10): 34-37
Martínez, A.; Pérez, P.; Ossa, C.; Corbalán, R.; Jalil, J.; Castro, P.; Acevedo, M. 2001: Hyperuricemia as a marker for anaerobic threshold in chronic cardiac failure Revista Medica de Chile 129(5): 503-508
Choon-ngarm, T.; Partpisanu, P. 2008: Serum cardiac troponin-T as a prognostic marker in septic shock Journal of the Medical Association of Thailand 91(12): 1818-1821
Acar, P.; Merlet, P.; Iserin, L.; Bonnet, D.; Aggoun, Y.; Sidi, D.; Kachaner, J. 1996: Cardiac MIBG imaging: a new marker for myocardial function in children? Archives des Maladies du Coeur et des Vaisseaux 89(5): 599-604
Khaspekov, G.L.; Sheremet'eva, G.F.; Skamrov, A.V.; Nechaenko, M.A.; Vinnitskiĭ, L.I.; Vlasik, T.N.; Goriunova, L.E.; Rutkevich, N.M.; Peklo, M.M.; Bibilashvili, R.Sh. 2008: Phospholipase A2, group IIa, as an earlier unknown immunohistological marker of cardiac myxoma Arkhiv Patologii 70(2): 31-36
Köseoğlu, V.; Berberoğlu, S.; Karademir, S.; Kismet, E.; Yurttutan, N.; Demirkaya, E.; Sungur, M.; Alehan, D. 2005: Cardiac troponin I: is it a marker to detect cardiotoxicity in children treated with doxorubicin? Turkish Journal of Pediatrics 47(1): 17-22